The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS
Open Access
- 21 July 2022
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (2) , 633-641
Abstract
To explore the associations of alanine aminotransferase in lean women of polycystic ovary syndrome (PCOS) with other biochemical parameters and the potential risk factors. This is a retrospective cohort study with lean PCOS (n = 91) and healthy controls (n = 45); we reviewed the electrical records and databases of the PCOS patients in our infertility clinic between January 2019 and September 2021; independent t-test, linear correlation analysis, and multiple linear regression were used to explore the associations. Higher levels of luteinizing hormone, total testosterone, thyroid stimulating hormone, platelet count, lymphocyte count, homocysteine, alanine aminotransferase (ALT), and uric acid were identified in lean PCOS patients, while follicle-stimulating hormone level was lower in in lean PCOS as expected (P < 0.05). Of note, the linear correlation showed that BMI, total testosterone, white blood cell count, lymphocyte count, aspartate aminotransferase, and uric acid were positively associated with alanine aminotransferase (r = 0.232, 0.318, 0.218, 0.388, 0.602, 0.353 respectively, P < 0.05). After multiple linear regression was performed, total testosterone and aspartate aminotransferase were independently and positively correlated with alanine aminotransferase in lean PCOS (B = 0.251, 0.605 respectively, P < 0.05). Higher level of ALT was identified in the lean PCOS. BMI, white blood cell count, lymphocyte count, aspartate aminotransferase, uric acid, and total testosterone were positively correlated with ALT in lean PCOS. Total testosterone and aspartate aminotransferase were independently and positively associated with ALT in lean PCOS after multiple linear regression. There might exist a potential risk of afflicting liver impairment for the lean PCOS women in the earlier period. Early examination and intervention might be necessary to prevent or delay the progression of the liver disease as soon as the diagnosis of PCOS.Keywords
This publication has 43 references indexed in Scilit:
- White blood cell differential counts in patients with polycystic ovary syndrome: a pilot study on Chinese womenEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Polycystic Ovary Syndrome: Focus on Platelets and Prothrombotic RiskSouthern Medical Journal, 2011
- Association between serum uric acid level and chronic liver disease in the United States†Hepatology, 2010
- Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjectsAtherosclerosis, 2009
- The role of hyperuricemia in vascular disordersCurrent Opinion in Rheumatology, 2009
- Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†Hepatology, 2008
- Obesity and immune cell counts in womenMetabolism, 2007
- Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non‐alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology, 2005
- The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrestHuman Reproduction Update, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004